Building Better Biomarkers: Brain Models in Translational Neuroimaging

Overview

Journal Nat Neurosci

Date 2017 Feb 24

PMID 28230847

Citations 410

Authors

Choong-Wan Woo

Luke J Chang

Martin A Lindquist

Tor D Wager

Affiliations

Soon will be listed here.

Abstract

Despite its great promise, neuroimaging has yet to substantially impact clinical practice and public health. However, a developing synergy between emerging analysis techniques and data-sharing initiatives has the potential to transform the role of neuroimaging in clinical applications. We review the state of translational neuroimaging and outline an approach to developing brain signatures that can be shared, tested in multiple contexts and applied in clinical settings. The approach rests on three pillars: (i) the use of multivariate pattern-recognition techniques to develop brain signatures for clinical outcomes and relevant mental processes; (ii) assessment and optimization of their diagnostic value; and (iii) a program of broad exploration followed by increasingly rigorous assessment of generalizability across samples, research contexts and populations. Increasingly sophisticated models based on these principles will help to overcome some of the obstacles on the road from basic neuroscience to better health and will ultimately serve both basic and applied goals.

Citing Articles

Neurofind: using deep learning to make individualised inferences in brain-based disorders.

Vieira S, Baecker L, Pinaya W, Garcia-Dias R, Scarpazza C, Calhoun V Transl Psychiatry. 2025; 15(1):69.

PMID: 40016187 PMC: 11868583. DOI: 10.1038/s41398-025-03290-x.

A longitudinal neuroimaging study of adolescent girls' mentalizing and perspective-taking tendencies.

Guazzelli Williamson V, Barendse M, Chavez S, Flournoy J, Cheng T, Cosme D Dev Cogn Neurosci. 2025; 72:101526.

PMID: 39983517 PMC: 11891602. DOI: 10.1016/j.dcn.2025.101526.

Stimulus Selection Influences Prediction of Individual Phenotypes in Naturalistic Conditions.

Li X, Eickhoff S, Weis S Hum Brain Mapp. 2025; 46(3):e70164.

PMID: 39960115 PMC: 11831449. DOI: 10.1002/hbm.70164.

Utilizing typical developmental trajectories to reflect brain abnormalities in autism spectrum disorder.

Cui L, Wang X, Wang H Psychoradiology. 2025; 4:kkae024.

PMID: 39872679 PMC: 11771376. DOI: 10.1093/psyrad/kkae024.

Generalisation of EEG-Based Pain Biomarker Classification for Predicting Central Neuropathic Pain in Subacute Spinal Cord Injury.

Anderson K, Stein S, Suen H, Purcell M, Belci M, McCaughey E Biomedicines. 2025; 13(1).

PMID: 39857795 PMC: 11759196. DOI: 10.3390/biomedicines13010213.

References

Doyle O, Westman E, Marquand A, Mecocci P, Vellas B, Tsolaki M . Predicting progression of Alzheimer's disease using ordinal regression. PLoS One. 2014; 9(8):e105542. PMC: 4139338. DOI: 10.1371/journal.pone.0105542. View

Chang L, Gianaros P, Manuck S, Krishnan A, Wager T . A Sensitive and Specific Neural Signature for Picture-Induced Negative Affect. PLoS Biol. 2015; 13(6):e1002180. PMC: 4476709. DOI: 10.1371/journal.pbio.1002180. View

Eloyan A, Muschelli J, Nebel M, Liu H, Han F, Zhao T . Automated diagnoses of attention deficit hyperactive disorder using magnetic resonance imaging. Front Syst Neurosci. 2012; 6:61. PMC: 3431009. DOI: 10.3389/fnsys.2012.00061. View

Casanova R, Hsu F, Sink K, Rapp S, Williamson J, Resnick S . Alzheimer's disease risk assessment using large-scale machine learning methods. PLoS One. 2013; 8(11):e77949. PMC: 3826736. DOI: 10.1371/journal.pone.0077949. View

. The ADHD-200 Consortium: A Model to Advance the Translational Potential of Neuroimaging in Clinical Neuroscience. Front Syst Neurosci. 2012; 6:62. PMC: 3433679. DOI: 10.3389/fnsys.2012.00062. View

Geurts J, Calabrese M, Fisher E, Rudick R . Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol. 2012; 11(12):1082-92. DOI: 10.1016/S1474-4422(12)70230-2. View

Hargreaves R, Hoppin J, Sevigny J, Patel S, Chiao P, Klimas M . Optimizing Central Nervous System Drug Development Using Molecular Imaging. Clin Pharmacol Ther. 2015; 98(1):47-60. DOI: 10.1002/cpt.132. View

Calhoun V, Maciejewski P, Pearlson G, Kiehl K . Temporal lobe and "default" hemodynamic brain modes discriminate between schizophrenia and bipolar disorder. Hum Brain Mapp. 2007; 29(11):1265-75. PMC: 2665178. DOI: 10.1002/hbm.20463. View

Diatchenko L, Nackley A, Slade G, Fillingim R, Maixner W . Idiopathic pain disorders--pathways of vulnerability. Pain. 2006; 123(3):226-230. DOI: 10.1016/j.pain.2006.04.015. View

10.

Logothetis N . What we can do and what we cannot do with fMRI. Nature. 2008; 453(7197):869-78. DOI: 10.1038/nature06976. View

11.

de Leon M, Ferris S, George A, Christman D, Fowler J, Gentes C . Positron emission tomographic studies of aging and Alzheimer disease. AJNR Am J Neuroradiol. 1983; 4(3):568-71. PMC: 8334899. View

12.

Widge A, Avery D, Zarkowski P . Baseline and treatment-emergent EEG biomarkers of antidepressant medication response do not predict response to repetitive transcranial magnetic stimulation. Brain Stimul. 2013; 6(6):929-31. PMC: 3834014. DOI: 10.1016/j.brs.2013.05.001. View

13.

Teune L, Renken R, Mudali D, de Jong B, Dierckx R, Roerdink J . Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord. 2013; 28(4):547-51. DOI: 10.1002/mds.25361. View

14.

Price R, Lane S, Gates K, Kraynak T, Horner M, Thase M . Parsing Heterogeneity in the Brain Connectivity of Depressed and Healthy Adults During Positive Mood. Biol Psychiatry. 2016; 81(4):347-357. PMC: 5215983. DOI: 10.1016/j.biopsych.2016.06.023. View

15.

Woo C, Wager T . Neuroimaging-based biomarker discovery and validation. Pain. 2015; 156(8):1379-1381. PMC: 4504798. DOI: 10.1097/j.pain.0000000000000223. View

16.

Tagliazucchi E, Laufs H . Decoding wakefulness levels from typical fMRI resting-state data reveals reliable drifts between wakefulness and sleep. Neuron. 2014; 82(3):695-708. DOI: 10.1016/j.neuron.2014.03.020. View

17.

Mather M, Cacioppo J, Kanwisher N . Introduction to the Special Section: 20 Years of fMRI-What Has It Done for Understanding Cognition?. Perspect Psychol Sci. 2015; 8(1):41-3. DOI: 10.1177/1745691612469036. View

18.

OReilly R . Biologically based computational models of high-level cognition. Science. 2006; 314(5796):91-4. DOI: 10.1126/science.1127242. View

19.

Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C . Network modulation in the treatment of Parkinson's disease. Brain. 2006; 129(Pt 10):2667-78. PMC: 4459513. DOI: 10.1093/brain/awl162. View

20.

Moradi E, Pepe A, Gaser C, Huttunen H, Tohka J . Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects. Neuroimage. 2014; 104:398-412. PMC: 5957071. DOI: 10.1016/j.neuroimage.2014.10.002. View